JP2022104951A5 - - Google Patents

Download PDF

Info

Publication number
JP2022104951A5
JP2022104951A5 JP2022054902A JP2022054902A JP2022104951A5 JP 2022104951 A5 JP2022104951 A5 JP 2022104951A5 JP 2022054902 A JP2022054902 A JP 2022054902A JP 2022054902 A JP2022054902 A JP 2022054902A JP 2022104951 A5 JP2022104951 A5 JP 2022104951A5
Authority
JP
Japan
Prior art keywords
bacteriophage
bacterium
target
dna sequence
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022054902A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022104951A (ja
JP7290368B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2016/037493 external-priority patent/WO2016205276A1/en
Application filed filed Critical
Publication of JP2022104951A publication Critical patent/JP2022104951A/ja
Publication of JP2022104951A5 publication Critical patent/JP2022104951A5/ja
Priority to JP2023084331A priority Critical patent/JP2023109907A/ja
Application granted granted Critical
Publication of JP7290368B2 publication Critical patent/JP7290368B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022054902A 2015-06-15 2022-03-30 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物 Active JP7290368B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023084331A JP2023109907A (ja) 2015-06-15 2023-05-23 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562175749P 2015-06-15 2015-06-15
US62/175,749 2015-06-15
PCT/US2016/037493 WO2016205276A1 (en) 2015-06-15 2016-06-15 Methods and compositions for efficient delivery of nucleic acids and rna-based antimicrobials
JP2017559861A JP7051438B2 (ja) 2015-06-15 2016-06-15 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017559861A Division JP7051438B2 (ja) 2015-06-15 2016-06-15 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023084331A Division JP2023109907A (ja) 2015-06-15 2023-05-23 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物

Publications (3)

Publication Number Publication Date
JP2022104951A JP2022104951A (ja) 2022-07-12
JP2022104951A5 true JP2022104951A5 (enExample) 2022-08-30
JP7290368B2 JP7290368B2 (ja) 2023-06-13

Family

ID=57546192

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017559861A Active JP7051438B2 (ja) 2015-06-15 2016-06-15 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物
JP2022054902A Active JP7290368B2 (ja) 2015-06-15 2022-03-30 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物
JP2023084331A Pending JP2023109907A (ja) 2015-06-15 2023-05-23 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017559861A Active JP7051438B2 (ja) 2015-06-15 2016-06-15 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023084331A Pending JP2023109907A (ja) 2015-06-15 2023-05-23 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物

Country Status (11)

Country Link
US (2) US11155823B2 (enExample)
EP (2) EP4299754A3 (enExample)
JP (3) JP7051438B2 (enExample)
KR (2) KR102468240B1 (enExample)
CN (2) CN115537421A (enExample)
AU (2) AU2016280002B2 (enExample)
CA (1) CA2983874C (enExample)
DK (1) DK3307872T3 (enExample)
ES (1) ES2960226T3 (enExample)
FI (1) FI3307872T3 (enExample)
WO (1) WO2016205276A1 (enExample)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013066438A2 (en) 2011-07-22 2013-05-10 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
US10584358B2 (en) 2013-10-30 2020-03-10 North Carolina State University Compositions and methods related to a type-II CRISPR-Cas system in Lactobacillus buchneri
US20150166984A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting alpha-antitrypsin point mutations
US10787654B2 (en) 2014-01-24 2020-09-29 North Carolina State University Methods and compositions for sequence guiding Cas9 targeting
EP3129490A4 (en) 2014-04-08 2017-10-04 North Carolina State University Methods and compositions for rna-directed repression of transcription using crispr-associated genes
AU2015298571B2 (en) 2014-07-30 2020-09-03 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
US10450584B2 (en) 2014-08-28 2019-10-22 North Carolina State University Cas9 proteins and guiding features for DNA targeting and genome editing
WO2016177682A1 (en) 2015-05-06 2016-11-10 Snipr Technologies Limited Altering microbial populations & modifying microbiota
WO2016196361A1 (en) 2015-05-29 2016-12-08 North Carolina State University Methods for screening bacteria, archaea, algae, and yeast using crispr nucleic acids
AU2016280002B2 (en) 2015-06-15 2022-04-14 North Carolina State University Methods and compositions for efficient delivery of nucleic acids and RNA-based antimicrobials
US11286480B2 (en) 2015-09-28 2022-03-29 North Carolina State University Methods and compositions for sequence specific antimicrobials
WO2017070632A2 (en) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
US11492670B2 (en) * 2015-10-27 2022-11-08 The Broad Institute Inc. Compositions and methods for targeting cancer-specific sequence variations
WO2017087909A1 (en) 2015-11-19 2017-05-26 Epibiome, Inc. Bacteriophage compositions and methods of use thereof
WO2017112620A1 (en) 2015-12-22 2017-06-29 North Carolina State University Methods and compositions for delivery of crispr based antimicrobials
GB201609811D0 (en) 2016-06-05 2016-07-20 Snipr Technologies Ltd Methods, cells, systems, arrays, RNA and kits
WO2018027078A1 (en) 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
AU2017308889B2 (en) 2016-08-09 2023-11-09 President And Fellows Of Harvard College Programmable Cas9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
KR20240007715A (ko) 2016-10-14 2024-01-16 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵염기 에디터의 aav 전달
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
JP7323178B2 (ja) * 2017-02-10 2023-08-08 イーティーエイチ・チューリッヒ L型細菌における合成バクテリオファージゲノムの再起動
WO2018165504A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Suppression of pain by gene editing
KR20190123328A (ko) 2017-03-09 2019-10-31 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 암 백신
CN110914310A (zh) 2017-03-10 2020-03-24 哈佛大学的校长及成员们 胞嘧啶至鸟嘌呤碱基编辑器
IL306092A (en) 2017-03-23 2023-11-01 Harvard College Nucleic base editors that include nucleic acid programmable DNA binding proteins
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
US20230193241A1 (en) * 2017-06-25 2023-06-22 Snipr Technologies Limited Altering microbial populations & modifying microbiota
EP3658573A1 (en) 2017-07-28 2020-06-03 President and Fellows of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
GB201712733D0 (en) * 2017-08-08 2017-09-20 Snipr Tech Ltd Methods & cells
CN107447044A (zh) * 2017-08-09 2017-12-08 华子昂 一种检测大肠杆菌λ噬菌体全基因组碱基修饰单倍型的方法
CN107365804B (zh) * 2017-08-13 2019-12-20 中国人民解放军疾病预防控制所 一种使用温和噬菌体载体包装CRISPR-Cas9系统的方法
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
CA3082251A1 (en) 2017-10-16 2019-04-25 The Broad Institute, Inc. Uses of adenosine base editors
US12406749B2 (en) 2017-12-15 2025-09-02 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
CN108300732A (zh) * 2018-02-23 2018-07-20 上海交通大学 一种高转化率运动发酵单胞菌及其构建方法和应用
CA3094458A1 (en) 2018-03-25 2019-10-31 Snipr Biome Aps. Treating & preventing microbial infections
US10760075B2 (en) 2018-04-30 2020-09-01 Snipr Biome Aps Treating and preventing microbial infections
KR20210018273A (ko) * 2018-05-04 2021-02-17 로커스 바이오사이언스, 인크. 표적 박테리아를 사멸시키기 위한 방법 및 조성물
WO2019225246A1 (ja) * 2018-05-22 2019-11-28 学校法人自治医科大学 抗菌ファージ、治療用組成物、殺菌剤、食品、細菌判別キット、治療用組成物製造方法、細菌除去方法、細菌判別方法、及び動物治療方法
WO2019226953A1 (en) 2018-05-23 2019-11-28 The Broad Institute, Inc. Base editors and uses thereof
US12227776B2 (en) 2018-06-13 2025-02-18 Caribou Biosciences, Inc. Engineered cascade components and cascade complexes
US10227576B1 (en) 2018-06-13 2019-03-12 Caribou Biosciences, Inc. Engineered cascade components and cascade complexes
EP3820495A4 (en) 2018-07-09 2022-07-20 The Broad Institute Inc. RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
US12264330B2 (en) 2018-10-01 2025-04-01 North Carolina State University Recombinant type I CRISPR-Cas system and uses thereof for killing target cells
US10711267B2 (en) 2018-10-01 2020-07-14 North Carolina State University Recombinant type I CRISPR-Cas system
US12203123B2 (en) 2018-10-01 2025-01-21 North Carolina State University Recombinant type I CRISPR-Cas system and uses thereof for screening for variant cells
WO2020072250A1 (en) 2018-10-01 2020-04-09 North Carolina State University Recombinant type i crispr-cas system and uses thereof for genome modification and alteration of expression
US11851663B2 (en) * 2018-10-14 2023-12-26 Snipr Biome Aps Single-vector type I vectors
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
CA3128507A1 (en) * 2019-02-06 2020-08-13 Fred Hutchinson Cancer Research Center Minicircle producing bacteria engineered to differentially methylate nucleic acid molecules therein
WO2020191241A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
WO2020214842A1 (en) 2019-04-17 2020-10-22 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
CN114981408A (zh) * 2019-11-06 2022-08-30 洛可斯生物科学公司 Crispr cas系统和溶原性模块
US20220370526A1 (en) * 2019-11-06 2022-11-24 Locus Biosciences, Inc. Phage compositions comprising crispr-cas systems and methods of use thereof
US11584781B2 (en) 2019-12-30 2023-02-21 Eligo Bioscience Chimeric receptor binding proteins resistant to proteolytic degradation
US11746352B2 (en) * 2019-12-30 2023-09-05 Eligo Bioscience Microbiome modulation of a host by delivery of DNA payloads with minimized spread
US12098372B2 (en) 2019-12-30 2024-09-24 Eligo Bioscience Microbiome modulation of a host by delivery of DNA payloads with minimized spread
CA3177481A1 (en) 2020-05-08 2021-11-11 David R. Liu Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
GB202007943D0 (en) 2020-05-27 2020-07-08 Snipr Biome Aps Products & methods
US12630846B2 (en) * 2020-06-05 2026-05-19 The Regents Of The University Of Michigan Type I-C CRISPR system from Neisseria lactamica and methods of use
US20240011041A1 (en) * 2020-11-05 2024-01-11 Locus Biosciences, Inc. Phage compositions for pseudomonas comprising crispr-cas systems and methods of use thereof
WO2022098899A1 (en) * 2020-11-05 2022-05-12 Locus Biosciences, Inc. Phage compositions for escherichia comprising crispr-cas systems and methods of use thereof
EP4370665A4 (en) * 2021-07-15 2025-08-13 Univ North Carolina State COMPOSITIONS, METHODS AND SYSTEMS FOR ENHANCED DNA TRANSFORMATION IN BACTERIA
WO2023111286A1 (en) 2021-12-17 2023-06-22 Snipr Biome Aps Nucleic acid delivery methods and compositions
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections
KR20250060133A (ko) 2023-10-24 2025-05-07 중앙대학교 산학협력단 CRISPR-Cas 탑재 박테리오파지 및 이의 용도
WO2025208072A1 (en) * 2024-03-29 2025-10-02 The General Hospital Corporation Methods and materials for treating disorders related to bacterial infections

Family Cites Families (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4723202A (en) 1987-04-02 1988-02-02 The Garrett Corporation Converter-fed AC machine without damper winding
IL128933A0 (en) 1999-03-11 2000-02-17 Mango Computers Ltd A system for convertinog high-level computer languages into specific low-level languages of digital signal processors
US6361634B1 (en) 2000-04-05 2002-03-26 Kimberly-Clark Worldwide, Inc. Multiple stage coating of elastic strands with adhesive
AU2002365188A1 (en) * 2001-11-07 2003-07-30 Musc Foundation For Research Development Nucleic acid delivery and expression
US7919277B2 (en) 2004-04-28 2011-04-05 Danisco A/S Detection and typing of bacterial strains
WO2006113709A2 (en) 2005-04-15 2006-10-26 Del Monte Fresh Produce Company Plant promoters, terminators, genes, vectors and related transformed plants
EP2325332B1 (en) 2005-08-26 2012-10-31 DuPont Nutrition Biosciences ApS Use of CRISPR associated genes (CAS)
ES2373586T3 (es) * 2006-05-19 2012-02-06 Danisco A/S Microorganismos marcados y métodos para marcar.
MX2009009071A (es) * 2007-03-02 2009-09-24 Danisco Cultivos con resistencia mejorada a fagos.
DK2362915T3 (en) 2008-11-07 2017-03-27 Dupont Nutrition Biosci Aps CRISPR SEQUENCES OF BIFIDOBACTERIA
WO2010075424A2 (en) 2008-12-22 2010-07-01 The Regents Of University Of California Compositions and methods for downregulating prokaryotic genes
DK2630156T3 (en) 2010-10-20 2018-12-17 Dupont Nutrition Biosci Aps CRISPR-CAS SEQUENCES OF LACTOCOCCUS
US20140113376A1 (en) 2011-06-01 2014-04-24 Rotem Sorek Compositions and methods for downregulating prokaryotic genes
WO2013000023A1 (en) * 2011-06-29 2013-01-03 Affinity Biosciences Pty Ltd Method of protein display
GB201122458D0 (en) * 2011-12-30 2012-02-08 Univ Wageningen Modified cascade ribonucleoproteins and uses thereof
US9637739B2 (en) 2012-03-20 2017-05-02 Vilnius University RNA-directed DNA cleavage by the Cas9-crRNA complex
WO2013141680A1 (en) 2012-03-20 2013-09-26 Vilnius University RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
ES2728782T3 (es) 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
KR20150023670A (ko) 2012-06-12 2015-03-05 제넨테크, 인크. 조건적 녹아웃 대립유전자의 생성 방법 및 이를 위한 조성물
WO2013188638A2 (en) 2012-06-15 2013-12-19 The Regents Of The University Of California Endoribonucleases and methods of use thereof
US20140025301A1 (en) 2012-07-20 2014-01-23 Bruce H. Storm, Jr. Determination of subsurface properties of a well
HK1207111A1 (en) 2012-08-03 2016-01-22 加利福尼亚大学董事会 Methods and compositions for controlling gene expression by rna processing
EP4397759A3 (en) 2012-10-23 2024-10-09 Toolgen Incorporated Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
US20150315576A1 (en) 2012-11-01 2015-11-05 Massachusetts Institute Of Technology Genetic device for the controlled destruction of dna
DK3363902T3 (da) 2012-12-06 2020-01-02 Sigma Aldrich Co Llc Crispr-baseret genommodifikation og -regulering
WO2014093479A1 (en) 2012-12-11 2014-06-19 Montana State University Crispr (clustered regularly interspaced short palindromic repeats) rna-guided control of gene regulation
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
KR102955556B1 (ko) 2012-12-12 2026-04-22 더 브로드 인스티튜트, 인코퍼레이티드 서열 조작을 위한 crispr-cas 성분 시스템, 방법 및 조성물
PT2931898E (pt) 2012-12-12 2016-06-16 Harvard College Manipulação e otimização de sistemas, métodos e composições para manipulação de sequências com domínios funcionais
CN105209621B (zh) 2012-12-12 2021-05-25 布罗德研究所有限公司 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化
WO2014093694A1 (en) 2012-12-12 2014-06-19 The Broad Institute, Inc. Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
IL308158A (en) 2012-12-17 2023-12-01 Harvard College Rna-guided human genome engineering
CA2897390A1 (en) 2013-01-10 2014-07-17 Ge Healthcare Dharmacon, Inc. Templates, libraries, kits and methods for generating molecules
WO2014113493A1 (en) 2013-01-16 2014-07-24 Emory University Cas9-nucleic acid complexes and uses related thereto
WO2014124226A1 (en) 2013-02-07 2014-08-14 The Rockefeller University Sequence specific antimicrobials
ES2749624T3 (es) 2013-03-14 2020-03-23 Caribou Biosciences Inc Composiciones y métodos de ácidos nucleicos dirigidos a ácido nucleico
US20140273230A1 (en) 2013-03-15 2014-09-18 Sigma-Aldrich Co., Llc Crispr-based genome modification and regulation
CN105408483A (zh) 2013-03-15 2016-03-16 通用医疗公司 遗传和表观遗传调节蛋白至特定基因组基因座的rna引导的靶向
JP2016512048A (ja) 2013-03-15 2016-04-25 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ CRISPR/Casシステムを使用した植物ゲノム操作
WO2014186686A2 (en) 2013-05-17 2014-11-20 Two Blades Foundation Targeted mutagenesis and genome engineering in plants using rna-guided cas nucleases
US9873907B2 (en) 2013-05-29 2018-01-23 Agilent Technologies, Inc. Method for fragmenting genomic DNA using CAS9
DK3004349T3 (en) 2013-05-29 2018-06-06 Cellectis Sa A method for producing precise DNA cleavage using CAS9 nickase activity
JP6608807B2 (ja) 2013-05-29 2019-11-20 セレクティス Rnaガイドcasヌクレアーゼ系を用いることによって免疫療法のためにt細胞を操作するための方法
EP3603679B1 (en) 2013-06-04 2022-08-10 President and Fellows of Harvard College Rna-guided transcriptional regulation
EP3008181B1 (en) 2013-06-11 2019-11-06 The Regents of The University of California Methods and compositions for target dna modification
ES2777217T3 (es) 2013-06-17 2020-08-04 Broad Inst Inc Suministro, modificación y optimización de sistemas de guía en tándem, métodos y composiciones para la manipulación de secuencias
EP3011033B1 (en) 2013-06-17 2020-02-19 The Broad Institute, Inc. Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
CN106133138A (zh) 2013-08-22 2016-11-16 先锋国际良种公司 使用引导多核苷酸/cas内切核酸酶系统的基因组修饰及其使用方法
EP4074330A1 (en) 2013-09-05 2022-10-19 Massachusetts Institute of Technology Tuning microbial populations with programmable nucleases
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
ES2681622T3 (es) 2013-09-18 2018-09-14 Kymab Limited Métodos, células y organismos
US20150098954A1 (en) 2013-10-08 2015-04-09 Elwha Llc Compositions and Methods Related to CRISPR Targeting
US10767156B2 (en) 2013-10-24 2020-09-08 Yeda Research And Development Co., Ltd. Polynucleotides encoding BREX system polypeptides and methods of using same
US10584358B2 (en) 2013-10-30 2020-03-10 North Carolina State University Compositions and methods related to a type-II CRISPR-Cas system in Lactobacillus buchneri
WO2015070193A1 (en) 2013-11-11 2015-05-14 Liu Oliver Compositions and methods for targeted gene disruption in prokaryotes
EP3760719A1 (en) 2013-11-18 2021-01-06 CRISPR Therapeutics AG Crispr-cas system materials and methods
US10787684B2 (en) 2013-11-19 2020-09-29 President And Fellows Of Harvard College Large gene excision and insertion
US20150166984A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting alpha-antitrypsin point mutations
JP6793547B2 (ja) 2013-12-12 2020-12-02 ザ・ブロード・インスティテュート・インコーポレイテッド 最適化機能CRISPR−Cas系による配列操作のための系、方法および組成物
EP3835419A1 (en) 2013-12-12 2021-06-16 The Regents of The University of California Methods and compositions for modifying a single stranded target nucleic acid
US10787654B2 (en) 2014-01-24 2020-09-29 North Carolina State University Methods and compositions for sequence guiding Cas9 targeting
EP3097212A4 (en) 2014-01-24 2017-10-04 North Carolina State University Methods and compositions for sequences guiding cas9 targeting
US9850525B2 (en) 2014-01-29 2017-12-26 Agilent Technologies, Inc. CAS9-based isothermal method of detection of specific DNA sequence
US10604802B2 (en) 2014-02-04 2020-03-31 Jumpcode Genomics, Inc. Genome fractioning
EP3126498A4 (en) 2014-03-20 2017-08-23 Université Laval Crispr-based methods and products for increasing frataxin levels and uses thereof
AU2015236045B2 (en) 2014-03-25 2021-09-23 Ginkgo Bioworks, Inc. Methods and genetic systems for cell engineering
WO2015153791A1 (en) 2014-04-01 2015-10-08 Editas Medicine, Inc. Crispr/cas-related methods and compositions for treating herpes simplex virus type 2 (hsv-2)
WO2015153889A2 (en) 2014-04-02 2015-10-08 University Of Florida Research Foundation, Incorporated Materials and methods for the treatment of latent viral infection
WO2015153940A1 (en) 2014-04-03 2015-10-08 Massachusetts Institute Of Technology Methods and compositions for the production of guide rna
EP3129490A4 (en) 2014-04-08 2017-10-04 North Carolina State University Methods and compositions for rna-directed repression of transcription using crispr-associated genes
AU2015248621B2 (en) 2014-04-14 2020-08-27 Nemesis Bioscience Ltd Therapeutic
ES2962509T3 (es) 2014-04-14 2024-03-19 Maxcyte Inc Métodos y composiciones para modificar ADN genómico
GB201406968D0 (en) 2014-04-17 2014-06-04 Green Biologics Ltd Deletion mutants
GB201406970D0 (en) 2014-04-17 2014-06-04 Green Biologics Ltd Targeted mutations
US11584936B2 (en) 2014-06-12 2023-02-21 King Abdullah University Of Science And Technology Targeted viral-mediated plant genome editing using CRISPR /Cas9
WO2015200555A2 (en) 2014-06-25 2015-12-30 Caribou Biosciences, Inc. Rna modification to engineer cas9 activity
US10450584B2 (en) 2014-08-28 2019-10-22 North Carolina State University Cas9 proteins and guiding features for DNA targeting and genome editing
CN107208070B (zh) 2014-11-26 2021-09-07 技术创新动力基金(以色列)有限合伙公司 细菌基因的靶向消除
US12129471B2 (en) 2015-02-23 2024-10-29 Vertex Pharmaceuticals Incorporated Materials and methods for treatment of human genetic diseases including hemoglobinopathies
WO2016177682A1 (en) 2015-05-06 2016-11-10 Snipr Technologies Limited Altering microbial populations & modifying microbiota
WO2016196361A1 (en) 2015-05-29 2016-12-08 North Carolina State University Methods for screening bacteria, archaea, algae, and yeast using crispr nucleic acids
AU2016280002B2 (en) 2015-06-15 2022-04-14 North Carolina State University Methods and compositions for efficient delivery of nucleic acids and RNA-based antimicrobials
US9580727B1 (en) 2015-08-07 2017-02-28 Caribou Biosciences, Inc. Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides
US10301613B2 (en) 2015-09-15 2019-05-28 Arizona Board Of Regents On Behalf Of Arizona State University Targeted remodeling of prokaryotic genomes using CRISPR-nickases
US20180258411A1 (en) 2015-09-25 2018-09-13 Tarveda Therapeutics, Inc. Compositions and methods for genome editing
US11286480B2 (en) 2015-09-28 2022-03-29 North Carolina State University Methods and compositions for sequence specific antimicrobials
WO2017066497A2 (en) 2015-10-13 2017-04-20 Duke University Genome engineering with type i crispr systems in eukaryotic cells
WO2017112620A1 (en) 2015-12-22 2017-06-29 North Carolina State University Methods and compositions for delivery of crispr based antimicrobials
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation
WO2018217981A1 (en) 2017-05-26 2018-11-29 North Carolina State University Altered guide rnas for modulating cas9 activity and methods of use

Similar Documents

Publication Publication Date Title
Mahler et al. Approaches for bacteriophage genome engineering
Han et al. CRISPR history: discovery, characterization, and prosperity
Gasiunas et al. Molecular mechanisms of CRISPR-mediated microbial immunity
AU2025203777A9 (en) CRISPR-Cas component systems, methods and compositions for sequence manipulation
Enyeart et al. Generalized bacterial genome editing using mobile group II introns and Cre-lox
AU2019229420A1 (en) Engineering of systems, methods and optimized guide compositions for sequence manipulation
CN108350453A (zh) 核酸酶dsb的完全查询和测序(find-seq)
CA2894684A1 (en) Engineering and optimization of improved crispr-cas systems, methods and enzyme compositions for sequence manipulation in eukaryotes
EP3872171A1 (en) Rna detection and transcription-dependent editing with reprogrammed tracrrnas
US20210108249A1 (en) Long Adapter Single Stranded Oligonucleotide (LASSO) Probes to Capture and Clone Complex Libraries
CN107488655A (zh) 测序文库构建中5’和3’接头连接副产物的去除方法
WO2016078096A1 (zh) 使用鼓泡状接头元件构建测序文库的方法
Glick et al. Medical biotechnology
JP7836831B2 (ja) インビボdnaアセンブリー及び解析
Yoon et al. A Noncontiguous Code for RNA-Guided DNA Recognition Preceded CRISPR
EP4628594A1 (en) Methods of amplifying dna and dna products with inhibitory regions
WO2023222014A1 (zh) sgRNA测序接头及其应用
Sridhara RNA-RNA ligation: Methods, prospects and applications
Chhetry et al. Csb1 moonlighting gives rise to functional redundancy with Csb2 in processing the pre-CRISPR transcript in type IG CRISPR-Cas system
CN117677694A (zh) 体内dna组装和分析
Zhang et al. Defect-complementation homologous recombination: A novel strategy for precise genome engineering of virulent phages
CN101311185A (zh) 一种基于半推理设计的基因体外定向进化体系
CN115927419A (zh) 一种基于2+N策略构建多靶点gRNA表达载体的方法及其应用
Stukenberg Establishing the fast-growing bacterium Vibrio natriegens as a next-generation chassis for synthetic biology
CN119286822A (zh) 一种化学诱导的多功能基因编辑系统及其应用